ReShape Lifesciences Pre-Tax Profit Margin 2015-2024 | RSLS
ReShape Lifesciences pre-tax profit margin from 2015 to 2024. Pre-tax profit margin can be defined as earnings before taxes as a portion of total revenue.
| ReShape Lifesciences Pre-Tax Profit Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Pre-Tax Income | Pre-Tax Margin |
| 2024-12-31 | $0.01B | $-0.01B | -100.00% |
| 2024-09-30 | $0.01B | $-0.01B | -100.00% |
| 2024-06-30 | $0.01B | $-0.01B | -125.00% |
| 2024-03-31 | $0.01B | $-0.01B | -137.50% |
| 2023-12-31 | $0.01B | $-0.01B | -150.00% |
| 2023-09-30 | $0.01B | $-0.03B | -300.00% |
| 2023-06-30 | $0.01B | $-0.04B | -360.00% |
| 2023-03-31 | $0.01B | $-0.04B | -381.82% |
| 2022-12-31 | $0.01B | $-0.05B | -427.27% |
| 2022-09-30 | $0.01B | $-0.07B | -609.09% |
| 2022-06-30 | $0.01B | $-0.07B | -600.00% |
| 2022-03-31 | $0.01B | $-0.07B | -515.38% |
| 2021-12-31 | $0.01B | $-0.06B | -457.14% |
| 2021-09-30 | $0.02B | $-0.04B | -218.75% |
| 2021-06-30 | $0.02B | $-0.02B | -137.50% |
| 2021-03-31 | $0.01B | $-0.02B | -157.14% |
| 2020-12-31 | $0.01B | $-0.02B | -183.33% |
| 2020-09-30 | $0.01B | $-0.02B | -237.50% |
| 2020-06-30 | $0.00B | $-0.02B | -450.00% |
| 2020-03-31 | $0.00B | $-0.02B | -1050.00% |
| 2019-12-31 | $0.00B | $-0.02B | -800.00% |
| 2019-09-30 | $0.00B | $-0.03B | -700.00% |
| 2019-06-30 | $0.01B | $-0.03B | -442.86% |
| 2019-03-31 | $0.01B | $-0.03B | -340.00% |
| 2018-12-31 | $0.01B | $-0.04B | -422.22% |
| 2018-09-30 | $0.01B | $-0.04B | -354.55% |
| 2018-06-30 | $0.01B | $-0.04B | -372.73% |
| 2018-03-31 | $0.01B | $-0.04B | -390.00% |
| 2017-12-31 | $0.01B | $-0.04B | -350.00% |
| 2017-09-30 | $0.01B | $-0.03B | -457.14% |
| 2017-06-30 | $0.01B | $-0.03B | -560.00% |
| 2017-03-31 | $0.00B | $-0.02B | -600.00% |
| 2016-12-31 | $0.00B | $-0.02B | -500.00% |
| 2016-06-30 | $0.00B | $-0.01B | -400.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | MED INSTRUMENTS | $0.004B | $0.008B |
| ReShape Lifesciences Inc. provides weight-loss solutions. It offers an integrated portfolio of proven products and services which manage and treat obesity and metabolic disease. ReShape Lifesciences Inc., formerly known as Obalon Therapeutics, is based in SAN CLEMENTE, CA. | |||